The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation
Open accessAbstract
Toll-like receptor 4 (TLR4) belongs to the family of pattern recognition receptors (PRRs). They are highly conserved receptors that recognize conserved pathogen-associated molecular patterns (PAMPs), thus representing the first line of defense against infections. TLR4 has been long recognized as the sensing receptor for gram-negative lipopolysaccharide (LPS). In addition, it also binds endogenous molecules produced as a result of tissue injury. Hence, TLR4 represents a key receptor on which both infectious and noninfectious stimuli converge to induce a proinflammatory response. TLR4-mediated inflammation, triggered by exogenous or endogenous ligands, is also involved in several acute and chronic diseases, having a pivotal role as amplifier of the inflammatory response. This review focuses on the research progress about the role of TLR4 activation in infectious and noninfectious (e.g., sterile) inflammation and the effects of TLR4 signaling in some pathological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
Park, B. S., Song, D. H., Kim, H. M., Choi, B.-S., Lee, H., & Lee, J.-O. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,428
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,185
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
Kurt-Jones, E. A., Popova, L., Kwinn, L., Haynes, L. M., Jones, L. P., Tripp, R. A., Walsh, E. E., Freeman, M. W., Golenbock, D. T., Anderson, L. J., et al. (2000) · Nature Immunology · doi:10.1038/80833 · Cited by 1,683
Ohashi, K., Burkart, V., Flohé, S., & Kolb, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.558 · Cited by 1,606
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
Qureshi, S. T., Larivière, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., & Malo, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.615 · Cited by 1,525
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · cited 1×
“In AD, amyloid-β (Aβ) oligomers directly induce microglial activation through several receptors, including TLR4 [49, 80].”
BackgroundNovel Signal Transduction Pathway Utilized by Extracellular HSP70
Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Baré, O., Auron, P. E., Stevenson, M. A., & Calderwood, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200497200 · Cited by 1,510
Akira, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300028200 · Cited by 1,479
Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A. D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1638 · Cited by 1,418 · cited 2×
“S100 proteins Agonist [45]”
BackgroundRegulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329
Toll-Like Receptor Signaling Pathways
Barton, G. M., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1085536 · Cited by 1,265
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
Olson, J. K., & Miller, S. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3916 · Cited by 1,215
Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran
Kim, H. M., Park, B. S., Kim, J.-I., Kim, S. E., Lee, J., Oh, S. C., Enkhbayar, P., Matsushima, N., Lee, H., Yoo, O. J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.002 · Cited by 1,177
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042614 · Cited by 1,113
Essential role of MD-2 in LPS responsiveness and TLR4 distribution
Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., Kimoto, M., & Miyake, K. (2002) · Nature Immunology · doi:10.1038/ni809 · Cited by 1,020
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Zanoni, I., Ostuni, R., Marek, L. R., Barresi, S., Barbalat, R., Barton, G. M., Granucci, F., & Kagan, J. C. (2011) · Cell · doi:10.1016/j.cell.2011.09.051 · Cited by 997
Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4
Smiley, S. T., King, J. A., & Hancock, W. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2887 · Cited by 946
Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2
Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A. K., Farber, J. M., Segal, D. M., Oppenheim, J. J., et al. (2002) · Science · doi:10.1126/science.1075565 · Cited by 902
MicroRNAs: the fine-tuners of Toll-like receptor signalling
O'Neill, L. A., Sheedy, F. J., & McCoy, C. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2957 · Cited by 856
Schaefer, L., Babelova, A., Kiss, E., Hausser, H.-J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23755 · Cited by 850
Maroso, M., Balosso, S., Ravizza, T., Liu, J., Aronica, E., Iyer, A. M., Rossetti, C., Molteni, M., Casalgrandi, M., Manfredi, A. A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2127 · Cited by 842
Self-citationTLR4 activation mediates kidney ischemia/reperfusion injury
Wu, H., Chen, G., Wyburn, K. R., Yin, J., Bertolino, P., Eris, J. M., Alexander, S. I., Sharland, A. F., & Chadban, S. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31008 · Cited by 836
Opal, S. M., Laterre, P.-F., Francois, B., LaRosa, S. P., Angus, D. C., Mira, J.-P., Wittebole, X., Dugernier, T., Perrotin, D., Tidswell, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.2194 · Cited by 812
Yang, H., Hreggvidsdottir, H. S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lu, B., Chavan, S., Rosas-Ballina, M., Al-Abed, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003893107 · Cited by 809
Does neuroinflammation fan the flame in neurodegenerative diseases?
Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751
Midwood, K., Sacre, S., Piccinini, A. M., Inglis, J., Trebaul, A., Chan, E., Drexler, S., Sofat, N., Kashiwagi, M., Orend, G., et al. (2009) · Nature Medicine · doi:10.1038/nm.1987 · Cited by 703
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697
Johnson, G. B., Brunn, G. J., Kodaira, Y., & Platt, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5233 · Cited by 648
Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
Frantz, S., Kobzik, L., Kim, Y.-D., Fukazawa, R., Medzhitov, R., Lee, R. T., & Kelly, R. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6709 · Cited by 645
Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice
Oyama, J.-I., Blais, C., Liu, X., Pu, M., Kobzik, L., Kelly, R. A., & Bourcier, T. (2004) · Circulation · doi:10.1161/01.cir.0000112575.66565.84 · Cited by 621
High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
Andrassy, M., Volz, H. C., Igwe, J. C., Funke, B., Eichberger, S. N., Kaya, Z., Buss, S., Autschbach, F., Pleger, S. T., Lukic, I. K., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.769331 · Cited by 620
Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke
Caso, J. R., Pradillo, J. M., Hurtado, O., Lorenzo, P., Moro, M. A., & Lizasoain, I. (2007) · Circulation · doi:10.1161/circulationaha.106.603431 · Cited by 606
Modhiran, N., Watterson, D., Muller, D. A., Panetta, A. K., Sester, D. P., Liu, L., Hume, D. A., Stacey, K. J., & Young, P. R. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3863 · Cited by 549
Hyaluronan Fragments Stimulate Endothelial Recognition of Injury through TLR4
Taylor, K. R., Trowbridge, J. M., Rudisill, J. A., Termeer, C. C., Simon, J. C., & Gallo, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310859200 · Cited by 545 · cited 1×
“TLR4 is expressed on the cell surface on both hematopoietic and nonhematopoietic cells, including endothelial cells [3], cardiac myocytes [4], and cells of the central nervous system (CNS) [5].”
BackgroundRole of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease
Walter, S., Letiembre, M., Liu, Y., Heine, H., Penke, B., Hao, W., Bode, B., Manietta, N., Walter, J., Schulz-Schüffer, W., et al. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110455 · Cited by 543
Endogenous toll‐like receptor ligands and their biological significance
Yu, L., Wang, L., & Chen, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01127.x · Cited by 532
Endogenous ligands of TLR2 and TLR4: agonists or assistants?
Erridge, C. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1209775 · Cited by 518
Vabulas, R. M., Braedel, S., Hilf, N., Singh-Jasuja, H., Herter, S., Ahmad-Nejad, P., Kirschning, C. J., da Costa, C., Rammensee, H.-G., Wagner, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200425200 · Cited by 488
The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451
miR-146a Is Critical for Endotoxin-induced Tolerance
Nahid, M. A., Pauley, K. M., Satoh, M., & Chan, E. K. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056317 · Cited by 423
Genetic variation in Toll-like receptors and disease susceptibility
Netea, M. G., Wijmenga, C., & O'Neill, L. A. J. (2012) · Nature Immunology · doi:10.1038/ni.2284 · Cited by 376
Extrathymic T-cell differentiation in vitro
Pawelec, G. (2004) · Nature Reviews Immunology · doi:10.1038/nri1257-c1 · Cited by 362
Toll‐like receptors in central nervous system glial inflammation and homeostasis
Kielian, T. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20767 · Cited by 361
Kawasaki, K., Akashi, S., Shimazu, R., Yoshida, T., Miyake, K., & Nishijima, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2251 · Cited by 355
Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene.
O'Brien, A. D., Rosenstreich, D. L., Scher, I., Campbell, G. H., MacDermott, R. P., & Formal, S. B. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.1.20 · Cited by 354
Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2
Ohto, U., Fukase, K., Miyake, K., & Shimizu, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201193109 · Cited by 352
MD-2 Binds to Bacterial Lipopolysaccharide
Viriyakosol, S., Tobias, P. S., Kitchens, R. L., & Kirkland, T. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105228200 · Cited by 312
Guillot, L., Balloy, V., McCormack, F. X., Golenbock, D. T., Chignard, M., & Si-Tahar, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.5989 · Cited by 299
Molecular Genetic Analysis of an Endotoxin Nonresponder Mutant Cell Line
Schromm, A. B., Lien, E., Henneke, P., Chow, J. C., Yoshimura, A., Heine, H., Latz, E., Monks, B. G., Schwartz, D. A., Miyake, K., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.1.79 · Cited by 297
Lehnardt, S., Schott, E., Trimbuch, T., Laubisch, D., Krueger, C., Wulczyn, G., Nitsch, R., & Weber, J. R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4760-07.2008 · Cited by 287
Resistin competes with lipopolysaccharide for binding to toll‐like receptor 4
Tarkowski, A., Bjersing, J., Shestakov, A., & Bokarewa, M. I. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00899.x · Cited by 284
Inhibition of Toll-like Receptor 4 With Eritoran Attenuates Myocardial Ischemia-Reperfusion Injury
Shimamoto, A., Chong, A. J., Yada, M., Shomura, S., Takayama, H., Fleisig, A. J., Agnew, M. L., Hampton, C. R., Rothnie, C. L., Spring, D. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.000901 · Cited by 284
Roelofs, M. F., Boelens, W. C., Joosten, L. A. B., Abdollahi-Roodsaz, S., Geurts, J., Wunderink, L. U., Schreurs, B. W., van den Berg, W. B., & Radstake, T. R. D. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7021 · Cited by 278
Song, M., Jin, J., Lim, J.-E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H.-D., Tahara, K., Lalonde, R., & Fukuchi, K.-I. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-92 · Cited by 273
Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons
Stefanova, N., Fellner, L., Reindl, M., Masliah, E., Poewe, W., & Wenning, G. K. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.013 · Cited by 272
Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4
Roger, T., Froidevaux, C., Le Roy, D., Reymond, M. K., Chanson, A.-L., Mauri, D., Burns, K., Riederer, B. M., Akira, S., & Calandra, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808146106 · Cited by 269
Functional Consequences of Toll-like Receptor 4 Polymorphisms
Ferwerda, B., McCall, M. B. B., Verheijen, K., Kullberg, B.-J., van der Ven, A. J. A. M., Van der Meer, J. W. M., & Netea, M. G. (2008) · Molecular Medicine · doi:10.2119/2007-00135.ferwerda · Cited by 260
Michaud, J.-P., Hallé, M., Lampron, A., Thériault, P., Préfontaine, P., Filali, M., Tribout-Jover, P., Lanteigne, A.-M., Jodoin, R., Cluff, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215165110 · Cited by 252
Nguyen, M. D., D'Aigle, T., Gowing, G., Julien, J.-P., & Rivest, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4786-03.2004 · Cited by 248
The new normal: immunomodulatory agents against sepsis immune suppression
Hutchins, N. A., Unsinger, J., Hotchkiss, R. S., & Ayala, A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.002 · Cited by 239
Tang, S.-C., Lathia, J. D., Selvaraj, P. K., Jo, D.-G., Mughal, M. R., Cheng, A., Siler, D. A., Markesbery, W. R., Arumugam, T. V., & Mattson, M. P. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.014 · Cited by 232
The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction
Terrando, N., Rei Fidalgo, A., Vizcaychipi, M., Cibelli, M., Ma, D., Monaco, C., Feldmann, M., & Maze, M. (2010) · Critical Care · doi:10.1186/cc9019 · Cited by 227
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
Chong, A. J., Shimamoto, A., Hampton, C. R., Takayama, H., Spring, D. J., Rothnie, C. L., Yada, M., Pohlman, T. H., & Verrier, E. D. (2004) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.11.036 · Cited by 222
Rallabhandi, P., Bell, J., Boukhvalova, M. S., Medvedev, A., Lorenz, E., Arditi, M., Hemming, V. G., Blanco, J. C. G., Segal, D. M., & Vogel, S. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.322 · Cited by 219
Epilepsy and Inflammation in the Brain: Overview and Pathophysiology
Vezzani, A. (2014) · Epilepsy Currents · doi:10.5698/1535-7511-14.s2.3 · Cited by 208
Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue
Casula, M., Iyer, A. M., Spliet, W. G. M., Anink, J. J., Steentjes, K., Sta, M., Troost, D., & Aronica, E. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.001 · Cited by 200 · cited 4×
“The studies about the role of TLR4 in other neurodegenerative and neurological diseases, ALS and epilepsy, gave more clear results.”
BackgroundInfluentialHua, F., Ma, J., Ha, T., Xia, Y., Kelley, J., Williams, D. L., Kao, R. L., William Browder, I., Schweitzer, J. B., Kalbfleisch, J. H., et al. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.08.014 · Cited by 200
Involvement of Toll-like Receptor (TLR) 2 and TLR4 in Cell Activation by Mannuronic Acid Polymers
Flo, T. H., Ryan, L., Latz, E., Takeuchi, O., Monks, B. G., Lien, E., Halaas, Ø., Akira, S., Skjåk-Bræk, G., Golenbock, D. T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201366200 · Cited by 196
Mazarati, A., Maroso, M., Iori, V., Vezzani, A., & Carli, M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.012 · Cited by 183
The sterile immune response during hepatic ischemia/reperfusion
van Golen, R. F., van Gulik, T. M., & Heger, M. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.006 · Cited by 171
Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
Noelker, C., Morel, L., Lescot, T., Osterloh, A., Alvarez-Fischer, D., Breloer, M., Henze, C., Depboylu, C., Skrzydelski, D., Michel, P. P., et al. (2013) · Scientific Reports · doi:10.1038/srep01393 · Cited by 164 · cited 1×
“In a mouse model of PD induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), TLR4 was shown to mediate cell death of dopaminergic neurons and TLR4-deficient mice were partially protected against MPTP toxicity [98].”
BackgroundThe extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4
Gondokaryono, S. P., Ushio, H., Niyonsaba, F., Hara, M., Takenaka, H., Jayawardana, S. T. M., Ikeda, S., Okumura, K., & Ogawa, H. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206730 · Cited by 164
Rajaiah, R., Perkins, D. J., Ireland, D. D. C., & Vogel, S. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424980112 · Cited by 155
Fang, H., Wu, Y., Huang, X., Wang, W., Ang, B., Cao, X., & Wan, T. Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.266528 · Cited by 131
Chase, M. A., Wheeler, D. S., Lierl, K. M., Hughes, V. S., Wong, H. R., & Page, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6318 · Cited by 111
Kaczorowski, D. J., Nakao, A., Vallabhaneni, R., Mollen, K. P., Sugimoto, R., Kohmoto, J., Zuckerbraun, B. S., McCurry, K. R., & Billiar, T. R. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a36e5e · Cited by 106
Frank, S., Copanaki, E., Burbach, G. J., Müller, U. C., & Deller, T. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.01.075 · Cited by 86 · cited 1×
“Increased expression of TLR4 in microglial cells has been observed in animal models and patients of Alzheimer’s disease (AD) [87– 89], Parkinson’s disease (PD) [90], and Amyotrophic Lateral Sclerosis (ALS) [91, 92].”
BackgroundMcDonald, K.-A., Huang, H., Tohme, S. T., Loughran, P., Ferrero, K. M., Billiar, T. R., & Tsung, A. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00076 · Cited by 82
Macagno, A., Molteni, M., Rinaldi, A., Bertoni, F., Lanzavecchia, A., Rossetti, C., & Sallusto, F. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060136 · Cited by 81
Self-citationToll-Like Receptor 4 Mediates the Early Inflammatory Response After Cold Ischemia/Reperfusion
Kaczorowski, D. J., Nakao, A., Mollen, K. P., Vallabhaneni, R., Sugimoto, R., Kohmoto, J., Tobita, K., Zuckerbraun, B. S., McCurry, K. R., Murase, N., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000287597.87571.17 · Cited by 77
De Paola, M., Mariani, A., Bigini, P., Peviani, M., Ferrara, G., Molteni, M., Gemma, S., Veglianese, P., Castellaneta, V., Boldrin, V., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00020 · Cited by 75 · cited 5×
“Increased expression of TLR4 in microglial cells has been observed in animal models and patients of Alzheimer’s disease (AD) [87– 89], Parkinson’s disease (PD) [90], and Amyotrophic Lateral Sclerosis (ALS) [91, 92].”
BackgroundInfluentialSelf-citationPanaro, M. A., Lofrumento, D. D., Saponaro, C., Nuccio, F. D., Cianciulli, A., Mitolo, V., & Nicolardi, G. (2008) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970802278557 · Cited by 75
Sato, K., Yoshimura, A., Kaneko, T., Ukai, T., Ozaki, Y., Nakamura, H., Li, X., Matsumura, H., Hara, Y., & Ogata, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338426 · Cited by 75
Fukusaki, T., Ohara, N., Hara, Y., Yoshimura, A., & Yoshiura, K.-I. (2007) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2007.00979.x · Cited by 69
Kutuzova, G. D., Albrecht, R. M., Erickson, C. M., & Qureshi, N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.482 · Cited by 61
Yang, S., Sugawara, S., Monodane, T., Nishijima, M., Adachi, Y., Akashi, S., Miyake, K., Hase, S., & Takada, H. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2025-2030.2001 · Cited by 57
Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection
Woods, J. P., Frelinger, J. A., Warrack, G. H., & Cannon, J. G. (1988) · Infection and Immunity · doi:10.1128/iai.56.8.1950-1955.1988 · Cited by 57
The effects of age on lipopolysaccharide-induced cognitive deficits and interleukin-1β expression
Tarr, A. J., McLinden, K. A., Kranjac, D., Kohman, R. A., Amaral, W. Z., & Boehm, G. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.10.036 · Cited by 50
Gomi, K., Kawasaki, K., Kawai, Y., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2939 · Cited by 47
Mansur, A., von Gruben, L., Popov, A., Steinau, M., Bergmann, I., Ross, D., Ghadimi, M. B., Beißbarth, T., Bauer, M., & Hinz, J. M. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-177 · Cited by 34
Role of toll-like receptors in liver transplantation
Howell, J. A., Gow, P. J., Angus, P., & Visvanathan, K. (2013) · Liver Transplantation · doi:10.1002/lt.23793 · Cited by 29
Calcineurin B stimulates cytokine production through a CD14‐independent Toll‐like receptor 4 pathway
Wu, W., Chen, Q., Geng, F., Li, T., Yang, R., Yang, J.-J., Zhang, H., Jia, Z., & Wei, Q. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.91 · Cited by 10
Cited by
TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling
Ciesielska, A., Matyjek, M., & Kwiatkowska, K. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03656-y · Cited by 1,420
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway
Zusso, M., Lunardi, V., Franceschini, D., Pagetta, A., Lo, R., Stifani, S., Frigo, A. C., Giusti, P., & Moro, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1538-9 · Cited by 534
Chitosan oligosaccharide: Biological activities and potential therapeutic applications
Muanprasat, C., & Chatsudthipong, V. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.013 · Cited by 520
Chitosan oligosaccharide (COS): An overview
Naveed, M., Phil, L., Sohail, M., Hasnat, M., Baig, M. M. F. A., Ihsan, A. U., Shumzaid, M., Kakar, M. U., Mehmood Khan, T., Akabar, M., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.192 · Cited by 508
Chen, X., Tang, J., Shuai, W., Meng, J., Feng, J., & Han, Z. (2020) · Inflammation Research · doi:10.1007/s00011-020-01378-2 · Cited by 423
Metadata
- Authors
- Molteni, M., Gemma, S., & Rossetti, C.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-9
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- OpenAlex
- W2403366498
- Cited by
- 446
- References
- 104
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.